| 摘要 |
<p>The invention relates to a porphyrin derivative, to the use thereof as a singlet oxygen generator and as an active component of pharmaceutical compositions for the treatment of cancer. According to the invention, the porphyrin derivative is 5-di[(3-hydroxy-4-methoxy)phenyl]-10,15,20-triphenyl-21H,23H porphyn(TMHAPP), of the following structural formula:</p> |
